P‐values and decision‐making: discussion of ‘Limitations of empirical calibration of p‐values using observational data’
暂无分享,去创建一个
[1] J. Rassen,et al. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. , 2013, The Journal of thoracic and cardiovascular surgery.
[2] K. Matthews,et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? , 1996, American journal of epidemiology.
[3] J. Avorn,et al. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.
[4] Sebastian Schneeweiss,et al. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. , 2006, Journal of clinical epidemiology.
[5] J. Avorn,et al. Paradoxical Relations of Drug Treatment with Mortality in Older Persons , 2001, Epidemiology.
[6] Sebastian Schneeweiss,et al. Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses. , 2015, American journal of epidemiology.
[7] J. Avorn,et al. Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial Results , 2007, Medical care.
[8] K. Dimopoulos,et al. Antidepressant use in pregnancy and the risk of cardiac defects. , 2014, The New England journal of medicine.
[9] N. Lazar,et al. The ASA Statement on p-Values: Context, Process, and Purpose , 2016 .
[10] J. Avorn,et al. A review of uses of health care utilization databases for epidemiologic research on therapeutics. , 2005, Journal of clinical epidemiology.
[11] S. Hernández-Díaz,et al. Statins and congenital malformations: cohort study , 2015, BMJ : British Medical Journal.
[12] William DuMouchel,et al. Interpreting observational studies: why empirical calibration is needed to correct p-values , 2013, Statistics in medicine.